| NCT ID | NCT07094256 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Minnesota |
| Condition | Electrophysiology Study |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2025-08-25 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 25 participants in total. It began in 2025-08-25 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will evaluate the safety and efficacy of a novel catheter torque device after the completion of a clinically-indicated electrophysiology study and/or ablation procedure in a pediatric patient. All electrophysiology studies and/or ablation procedures will be performed at the discretion of their primary cardiologist and will not be affected by this study protocol. The study protocol will commence once the attending electrophysiologist has completed all necessary intervention and testing and no further evaluation is required.
Eligibility Criteria
Inclusion Criteria: * Pediatric patient (≤21 years of age) * Undergoing clinically-indicated electrophysiology study and/or ablation procedure Exclusion Criteria: * Adult patient (\>21 years)
Contact & Investigator
Bradley Clark
PRINCIPAL INVESTIGATOR
University of Minnesota
Frequently Asked Questions
Who can join the NCT07094256 clinical trial?
This trial is open to participants of all sexes, up to 21 Years, studying Electrophysiology Study. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07094256 currently recruiting?
Yes, NCT07094256 is actively recruiting participants. Contact the research team at clarkb@umn.edu for enrollment information.
Where is the NCT07094256 trial being conducted?
This trial is being conducted at Washington D.C., United States, Minneapolis, United States.
Who is sponsoring the NCT07094256 clinical trial?
NCT07094256 is sponsored by University of Minnesota. The principal investigator is Bradley Clark at University of Minnesota. The trial plans to enroll 25 participants.